Skip to:
-

Blood Cells and Blood Cancer

Our division investigates the processes that drive normal blood cell development. We aim to identify the nature of defects that subvert these processes, causing the development of cancer.

Sections on this page

Leadership and management

Professor Andreas Strasser
Division Head
Theme Leader
Sue Hardy
Division Coordinator
Michelle Birrell
Division Coordinator
Prof Jerry Adams
Honorary Research Fellow
Prof Suzanne Cory
Honorary Distinguished Research Fellow
Laboratory Head
Director
Laboratory Head
Portrait of Gemma Kelly
Laboratory Head
Laboratory Head
Laboratory Head
Theme Leader

About

Collaborations between our researchers, biotech and pharmaceutical companies have led to the development of drugs that have been approved or are currently being tested in clinical trials for the treatment of blood cancers and other diseases.

Building on this, we continue to focus our efforts on developing improved treatments for people with cancer and to make the basic research discoveries that will lead to future breakthrough cancer therapies.

To contact the division please email our Division Coordinators:

Division news

Cancer mutation discovery could improve targeted leukaemia treatment
04 December 2018
Mutant protein tackles DNA guardian to promote cancer development
06 November 2018
New model mimics human tumours for accurate testing of cancer drugs
11 October 2018
New clues about how our body guards against cancer
04 October 2018
Team behind new cancer drug wins Clunies Ross Award
13 June 2018
View all news
© WEHI 2023
Close